| IRF4 and IRF8: Governing the virtues of B Lymphocytes V Shukla, R Lu Frontiers in biology 9, 269-282, 2014 | 85 | 2014 |
| TET enzymes augment activation-induced deaminase (AID) expression via 5-hydroxymethylcytosine modifications at the Aicda superenhancer CWJ Lio, V Shukla, D Samaniego-Castruita, E González-Avalos, ... Science immunology 4 (34), eaau7523, 2019 | 84 | 2019 |
| A role for IRF4 in the development of CLL V Shukla, S Ma, RR Hardy, SS Joshi, R Lu Blood, The Journal of the American Society of Hematology 122 (16), 2848-2855, 2013 | 64 | 2013 |
| HMCES functions in the alternative end-joining pathway of the DNA DSB repair during class switch recombination in B cells V Shukla, L Halabelian, S Balagere, D Samaniego-Castruita, DE Feldman, ... Molecular cell 77 (2), 384-394. e4, 2020 | 61 | 2020 |
| TET deficiency perturbs mature B cell homeostasis and promotes oncogenesis associated with accumulation of G-quadruplex and R-loop structures V Shukla, D Samaniego-Castruita, Z Dong, E González-Avalos, Q Yan, ... Nature immunology 23 (1), 99-108, 2022 | 45 | 2022 |
| Promoter hypomethylation and expression is conserved in mouse chronic lymphocytic leukemia induced by decreased or inactivated Dnmt3a SL Haney, GM Upchurch, J Opavska, D Klinkebiel, RA Hlady, A Suresh, ... Cell Reports 15 (6), 1190-1201, 2016 | 39 | 2016 |
| Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL A Shukla, K Rai, V Shukla, NK Chaturvedi, RG Bociek, SJ Pirruccello, ... Blood, The Journal of the American Society of Hematology 127 (19), 2310-2321, 2016 | 28 | 2016 |
| Accelerated development of chronic lymphocytic leukemia in New Zealand Black mice expressing a low level of interferon regulatory factor 4 S Ma, V Shukla, L Fang, KA Gould, SS Joshi, R Lu Journal of Biological Chemistry 288 (37), 26430-26440, 2013 | 25 | 2013 |
| HMCES protects immunoglobulin genes specifically from deletions during somatic hypermutation L Wu, V Shukla, AD Yadavalli, RK Dinesh, D Xu, A Rao, DG Schatz Genes & Development 36 (7-8), 433-450, 2022 | 23 | 2022 |
| Interferon regulatory factor 4 attenuates Notch signaling to suppress the development of chronic lymphocytic leukemia V Shukla, A Shukla, SS Joshi, R Lu Oncotarget 7 (27), 41081, 2016 | 22 | 2016 |
| A role for IRF8 in B cell anergy S Pathak, S Ma, V Shukla, R Lu The Journal of Immunology 191 (12), 6222-6230, 2013 | 22 | 2013 |
| Regulation of MAPK signaling and implications in chronic lymphocytic leukemia A Shukla, V Shukla, SS Joshi Leukemia & Lymphoma 59 (7), 1565-1573, 2018 | 19 | 2018 |
| Toward a systems-level probing of tumor clonality EI Grody, A Abraham, V Shukla, Y Goyal Iscience 26 (5), 2023 | 2 | 2023 |
| Endothelial Jagged1 levels and distribution are post-transcriptionally controlled by ZFP36 decay proteins HL Sunshine, AC Cicchetto, KE Kaczor-Urbanowicz, F Ma, D Pi, ... Cell reports 43 (1), 2024 | 1 | 2024 |
| Alternative DNA structures in hematopoiesis and adaptive immunity. H Kligfeld, I Han, A Abraham, V Shukla Advances in Immunology 161, 109-126, 2024 | | 2024 |
| Arid1a-dependent canonical BAF complex suppresses inflammatory programs to drive efficient Germinal Center B cell responses A Abraham, D Samaniego-Castruita, J Paladino, I Han, P Ramesh, ... | | 2024 |
| Enhancement of mitochondrial function fosters B cell immune memory A Shukla, A Tiwari, O Saulnier, L Hendrikse, B Hall, R Rickert, MD Taylor, ... bioRxiv, 2022.06. 21.497040, 2022 | | 2022 |
